Angela Hammer

Title: Angela Hammer - Innovator in Nanoparticle Technology

Introduction

Angela Hammer is a prominent inventor based in Stuttgart, Germany. She has made significant contributions to the field of nanoparticle technology, particularly in the area of biologically active compounds. Her innovative work focuses on the development of nanoparticles that can be utilized in therapeutic applications, especially in cancer treatment.

Latest Patents

Angela Hammer holds a patent for "Nanoparticles comprising biologically active TNF which is immobilized on the same." This invention relates to nanoparticles that incorporate tumor necrosis factor (TNF) or cytokines immobilized in a directed manner while retaining their biological activity. The patent outlines methods for the directed immobilization of TNF or cytokines on nanoparticles, as well as their applications in identifying and isolating binding partners and inhibitors. Furthermore, these nanoparticles can be used to prepare pharmaceutical compositions aimed at tumor therapy.

Career Highlights

Angela Hammer is associated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in Germany. Her work has been instrumental in advancing the understanding and application of nanoparticles in medical science. With a focus on innovative solutions, she continues to contribute to the field through her research and inventions.

Collaborations

Angela collaborates with esteemed colleagues such as Günter Tovar and Thomas Schiestel. Their combined expertise enhances the research and development efforts in nanoparticle technology, leading to groundbreaking advancements in the field.

Conclusion

Angela Hammer's contributions to nanoparticle technology exemplify the impact of innovative research in medicine. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.